355 related articles for article (PubMed ID: 19566446)
1. Targeting anti-HIV drugs to the CNS.
Rao KS; Ghorpade A; Labhasetwar V
Expert Opin Drug Deliv; 2009 Aug; 6(8):771-84. PubMed ID: 19566446
[TBL] [Abstract][Full Text] [Related]
2. Approaches for CNS delivery of drugs - nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment.
Gupta S; Kesarla R; Omri A
Expert Opin Drug Deliv; 2019 Mar; 16(3):287-300. PubMed ID: 30779602
[TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier and neuro-AIDS.
Zhang YL; Ouyang YB; Liu LG; Chen DX
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4927-39. PubMed ID: 26744885
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers for brain specific delivery of anti-retro viral drugs: challenges and achievements.
Varghese NM; Senthil V; Saxena SK
J Drug Target; 2018 Mar; 26(3):195-207. PubMed ID: 28866957
[TBL] [Abstract][Full Text] [Related]
5. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.
Gong Y; Zhi K; Nagesh PKB; Sinha N; Chowdhury P; Chen H; Gorantla S; Yallapu MM; Kumar S
Viruses; 2020 May; 12(5):. PubMed ID: 32443728
[TBL] [Abstract][Full Text] [Related]
6. Advances in brain targeting and drug delivery of anti-HIV therapeutic agents.
Al-Ghananeem AM; Smith M; Coronel ML; Tran H
Expert Opin Drug Deliv; 2013 Jul; 10(7):973-85. PubMed ID: 23510097
[TBL] [Abstract][Full Text] [Related]
7. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
8. Nanoformulated Antiretrovirals for Penetration of the Central Nervous System: State of the Art.
Fiandra L; Capetti A; Sorrentino L; Corsi F
J Neuroimmune Pharmacol; 2017 Mar; 12(1):17-30. PubMed ID: 27832401
[TBL] [Abstract][Full Text] [Related]
9. TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs.
Rao KS; Reddy MK; Horning JL; Labhasetwar V
Biomaterials; 2008 Nov; 29(33):4429-38. PubMed ID: 18760470
[TBL] [Abstract][Full Text] [Related]
10. Directing the Antiretroviral Drugs to the Brain Reservoir: A Nanoformulation Approach for NeuroAIDS.
Nabi B; Rehman S; Pottoo FH; Baboota S; Ali J
Curr Drug Metab; 2021; 22(4):280-286. PubMed ID: 32964821
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology applications for improved delivery of antiretroviral drugs to the brain.
Wong HL; Chattopadhyay N; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2010 Mar; 62(4-5):503-17. PubMed ID: 19914319
[TBL] [Abstract][Full Text] [Related]
12. Targeting strategies for delivery of anti-HIV drugs.
Ramana LN; Anand AR; Sethuraman S; Krishnan UM
J Control Release; 2014 Oct; 192():271-83. PubMed ID: 25119469
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.
DeMarino C; Schwab A; Pleet M; Mathiesen A; Friedman J; El-Hage N; Kashanchi F
J Neuroimmune Pharmacol; 2017 Mar; 12(1):31-50. PubMed ID: 27372507
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 persistence in the CNS: Mechanisms of latency, pathogenesis and an update on eradication strategies.
Sonti S; Sharma AL; Tyagi M
Virus Res; 2021 Oct; 303():198523. PubMed ID: 34314771
[TBL] [Abstract][Full Text] [Related]
15. Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy.
Martins C; Araújo F; Gomes MJ; Fernandes C; Nunes R; Li W; Santos HA; Borges F; Sarmento B
Eur J Pharm Biopharm; 2019 May; 138():111-124. PubMed ID: 29397261
[TBL] [Abstract][Full Text] [Related]
16. Target Molecules and Delivery Vehicles for Anti-HIV Drugs In vitro and In vivo.
Bolhassani A
Curr Pharm Des; 2018; 24(29):3393-3401. PubMed ID: 29886823
[TBL] [Abstract][Full Text] [Related]
17. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
Shahjin F; Chand S; Yelamanchili SV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
[TBL] [Abstract][Full Text] [Related]
18. HIV pharmacology: barriers to the eradication of HIV from the CNS.
McGee B; Smith N; Aweeka F
HIV Clin Trials; 2006; 7(3):142-53. PubMed ID: 16880170
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in drug targets and delivery of anti-HIV drugs.
Salama NN; Endsley A; Ho RJ
Infect Disord Drug Targets; 2006 Jun; 6(2):107-19. PubMed ID: 16789874
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.
Mahajan SD; Roy I; Xu G; Yong KT; Ding H; Aalinkeel R; Reynolds J; Sykes D; Nair BB; Lin EY; Prasad PN; Schwartz SA
Curr HIV Res; 2010 Jul; 8(5):396-404. PubMed ID: 20426757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
